Cambium Bio Ltd (CMB) — Capital Reinvestment Ratio
Latest as of December 2023:
0.02x
Cambium Bio Ltd (CMB) has a Capital Reinvestment Ratio of 0.02x as of December 2023, meaning it reinvests 0% of its operating cash flow (AU$148.25K) in capital expenditures (AU$2.27K). See CMB net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
AU$148.25K
AUD
Capital Expenditures
AU$2.27K
AUD
Data as of
Dec 2023
Most recent filing
Cambium Bio Ltd Capital Reinvestment Ratio (1999–2021)
This chart tracks Cambium Bio Ltd's Capital Reinvestment Ratio across 6 annual periods. Check CMB total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Cambium Bio Ltd (1999–2021)
Year-by-year Capital Reinvestment Ratio for Cambium Bio Ltd from 1999 to 2021. For live market cap and broader valuation context, see CMB company net worth.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | AU$2.42 Million | AU$7.78K | ▼ -92.3% |
| 2017 | 0.04x | AU$3.59 Million | AU$149.95K | ▼ -96.2% |
| 2002 | 1.11x | AU$5.43 Million | AU$6.01 Million | ▲ +107.3% |
| 2001 | 0.53x | AU$38.20 Million | AU$20.40 Million | ▲ +115.7% |
| 2000 | 0.25x | AU$48.26 Million | AU$11.95 Million | ▼ -54.9% |
| 1999 | 0.55x | AU$33.43 Million | AU$18.35 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow